Clinical Trial Update: Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing surfactant administration to nasal continuous positive airway pressure for respiratory distress syndrome in newborns ≥35 weeks gestati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Acute Respiratory Distress Syndrome | Phase 3 | Status: TERMINATED